Lake Street Maintains Buy on OptimizeRx, Lowers Price Target to $10
Lake Street analyst Eric Martinuzzi maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $11 to $10.
Last updated: 2026-11-19 12:44:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
OptimizeRx Corporation (OPRX) operates in the SERVICES-BUSINESS SERVICES, NEC sector and is listed on NASDAQ. The stock is currently priced at $7.32, with a market capitalization of $131.21M and a P/E ratio of 26.15. Over the past 52 weeks, its price has ranged from $4.54 to $15.59. This page covers its latest market performance, valuation, price trends and company information.
$131.21M | |
$6.98 | |
$7.44 | |
$6.85 | |
$6.94 | |
170.86K | |
191.15K | |
26.15 | |
$15.59 | |
$4.54 | |
-- | |
2026-09-30 |
OptimizeRx Corporation (OPRX) is trading at $7.07 in pre-market trading as of 2026-11-19 00:31:00, up 1.89% ($0.13) from the previous close of $6.94
Pre-market trading shows how investors are pricing OPRX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, OptimizeRx Corporation (OPRX) moved from $9.35 to $7.32, representing a decline of 21.76% ($2.03).
The stock traded between $6.33 and $9.83 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 481.96 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 25.1%
OPRX is currently trading at $7.32, placing it 25.1% of the way from its 52-week low of $4.54 to its 52-week high of $15.59. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
| Industry | SERVICES-BUSINESS SERVICES, NEC |
| Employees | 105 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to OptimizeRx Corporation and OPRX stock.
Lake Street analyst Eric Martinuzzi maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $11 to $10.
OptimizeRx beat Q3 earnings and sales estimates but cut FY2026 revenue guidance; shares fell 17.3% as analysts lowered price targets.
Gainers Addex Therapeutics (NASDAQ:ADXN) stock moved upwards by 73.5% to $5.01 during Thursday's regular session. enGene Therapeutics (NASDAQ:ENGN) stock rose 29.37% to $2.33. The company's market cap stands
B. Riley Securities analyst Josh Nichols reiterates OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $11 to $10.5.
Gainers Addex Therapeutics (NASDAQ:ADXN) stock rose 74.0% to $5.03 during Thursday's pre-market session. ZeroStack (NASDAQ:ZSTK) stock increased by 11.56% to $2.99. The market value of their outstanding shares is
Eligible investors can buy real shares of OptimizeRx Corporation (OPRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to OPRX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between OPRX shares and USD.
OPRX Shares to USD
1.00 OPRX shares = 7.315 USD
Calculations are estimates based on the latest available price and are for reference only.